期刊文献+

617例肿瘤患者血清12种肿瘤标志物检测 被引量:4

Detection of 12 tumor markers in 612 cases of malignant tumor
下载PDF
导出
摘要 目的 报道多种瘤标志物蛋白芯片检测系统定量测定肿瘤患者血清中 12种肿瘤标志物的实验结果。方法 用蛋白芯片技术定量测定 6 17例肿瘤患者和 36例正常人血清中 12种常见肿瘤标志物 :癌抗原 19 9(CA19 9)、神经元特异性烯醇化酶 (NSE)、铁蛋白 (Ferritin)、β 绒毛膜促性腺素 (β HCG)、甲胎蛋白 (AFP)、癌胚抗原 (CEA )、癌抗原 2 4 2(CA2 4 2 )、游离前列腺特异性抗原 (F PSA)、前列腺特异性抗原 (PSA)、癌抗原 12 5 (CA12 5 )、人体生长激素 (HGH)和癌抗原15 3(CA15 3)。结果 阳性率超过 5 0 %是 :肝癌的阳性率(AFP、CA2 4 2、CA12 5、Ferritin)分别为 86 96 %、5 2 17%、5 4 35 %、5 0 0 0 % ;肺癌的阳性率 (NSE、Fessitin)分别为5 4 93%、5 0 34% ;胃癌阳性率 (CA19 9)为 5 7 90 % ;结肠癌阳性率 (CA2 4 2 )为 5 9 5 2 %。它们的特异度均 >96 0 %。结论 采用蛋白芯片技术同时测定肿瘤患者血清中多肿瘤标志物 ,方法简便 ,价格低廉 。 Objective To study multi-tumor marker protein chip diagnose systerm to detect the values of serum 12 tumor markers in malignant tumor patients.Methods Using protein chip to determine and analyse the concentration of 12tumor markers (CA19-9, NSE, Ferritin, β-HCG, AFP, CEA, CA-242, f-PSA, PSA, CA125, HGH, CA153) in 617 malignant tumor patients and 36 controls.Result The positive ratio of liver conce (AFP, CA242, CA125, Ferritin) was 86.96%, 52.17%, 54.35%, 50.00%,respectively. The positive ratio of lung conce(NSE,Ferritin)was 54.93%, 50.34%;the gastric cancer (CA19-9) was 57.91% and the colon cancer(CA242) was 59.52%. Specificity of these indicators all exceeded 96.0%. Conclusion Multi-tumor marker levels in serum can be deteded by using protein chip. The method is cheap, convenient and can provide much more information for clinic diagnosis.
出处 《安徽医科大学学报》 CAS 2004年第5期396-398,共3页 Acta Universitatis Medicinalis Anhui
关键词 肿瘤标志物 生物学 蛋白芯片 tumor markers,biological
  • 相关文献

参考文献4

  • 1巴德年主编.当代免疫学技术与应用. 北京:北京医科大学中国协和医科大学联合出版社,1998:927
  • 2Cestra G,Castagnoli L, Dente L et al.The SH3 domains of endorphin and amphiphysin bind to the proline-rich region of synatojan in 1 at distinct sites that display an unconventional binding specificity.J Biol Chem,1999;274 (5):32001~7
  • 3张乐之,龚燕芳,沈茜,徐忠玉,万里军.胰腺癌患者血清十二种肿瘤标记物的变化[J].胰腺病学,2002,2(3):151-154. 被引量:11
  • 4戴光强主编. 医学科学研究与论文写作. 合肥:安徽科学技术出版社,2001:145

二级参考文献6

  • 1Banfi G, Bravi S, Ardemagni A, et al.CA19-9,CA242 and CEA in the diagnosis and follow-up of pancreatic cancer.Int J Biol Markers,1996,2:77-81.
  • 2Furuya N, Kawa S, Hasebe O, et al. Comparative study of CA242 and CA19-9 in chronic pancreatitis. Br J Cancer, 1996, 3:372-376.
  • 3Nishida K, Kaneko T, Yoneda M, et al. Doubling time of serum CA19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis.J Surg Oncol, 1999, 3:140-146.
  • 4Kim H J,Kim M H,Myung S J,et al.A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer:analysis using a receiver operating characteristic curve.Am J Gastroenterol, 1999, 7:1941-1946.
  • 5王平,李玉明.血清CA19-9、CA24-2、CEA联合检测在胰癌诊断中的价值[J].南通医学院学报,1997,17(4):488-489. 被引量:6
  • 6张乐之,龚燕芳,屠振兴.胰腺癌患者血清CA242定量测定及其意义[J].胰腺病学,2002,2(1):20-21. 被引量:28

共引文献10

同被引文献27

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部